REACTINE ALLERGY
REACTINE ALLERGY
Approved
DIN Number
02486954
Drug Class
Human
Market Date
Feb 6, 2020
Company
HC
mcneil consumer healthcare division of johnson & johnson inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02486954
AIG Number0122686004
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R06AE07 CETIRIZINE
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification04:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CETIRIZINE HYDROCHLORIDEActive
Strength: 5 MG / 5 ML
Monograph: CETIRIZINE HYDROCHLORIDE